Co-Authors
This is a "connection" page, showing publications co-authored by Peter Kremsner and Dominik Vahrenhorst.
Connection Strength
0.240
-
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial. Wien Klin Wochenschr. 2021 Sep; 133(17-18):931-941.
Score: 0.240
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.